Hannah H. Ahn

ORCID: 0000-0003-0040-1552
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Telemedicine and Telehealth Implementation
  • Healthcare cost, quality, practices
  • Cancer survivorship and care
  • Antimicrobial Resistance in Staphylococcus
  • Health Systems, Economic Evaluations, Quality of Life
  • Drug-Induced Adverse Reactions
  • COVID-19 and healthcare impacts
  • Economic and Financial Impacts of Cancer
  • Streptococcal Infections and Treatments

Mayo Clinic in Arizona
2023

Pennsylvania State University
2020

Background: Cost-effectiveness analysis is an important tool for informing treatment coverage and pricing decisions, yet no consensus exists about what threshold the incremental cost-effectiveness ratio (ICER) in dollars per quality-adjusted life-year (QALY) gained indicates whether treatments are likely to be cost-effective United States. Objective: To estimate a U.S. based on health opportunity costs. Design: Simulation of short-term mortality morbidity attributable persons dropping...

10.7326/m20-1392 article EN Annals of Internal Medicine 2020-11-02

In response to the COVID-19 pandemic, many cancer practices rapidly adopted telehealth services. However, there is a paucity of data regarding ongoing visit utilization beyond this initial response. The purpose study was assess changes in variables associated with over time.

10.1200/op.23.00118 article EN cc-by-nc-nd JCO Oncology Practice 2023-06-19

True penicillin allergy is rare and commonly incorrectly reported. In fact, less than five percent of patients who report a will have currently active clinically-significant IgE- or T-cell-mediated hypersensitivity when appropriately tested. Penicillin the agent choice for intrapartum antibiotic prophylaxis to reduce risk group B streptococcus early-onset disease in newborn. Inaccurate status may lead inappropriate use, as most alternative drugs are more expensive broader spectrum...

10.1371/journal.pone.0280151 article EN cc-by PLoS ONE 2023-01-20
Coming Soon ...